Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial

PLoS Medicine(2020)10.1371/journal.pmed.1003051Source: DataRank Database

Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial is a research paper published in PLoS Medicine (2020). On theSindex it has a DataRank of 4.8. It has been cited 321 times, with 100 citing works in its 1-hop citation network.

N/A

4.8DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access321 citations · 100 citing works in its network

Free full text

Cite:

Linked data & code

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02530385

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 14.08)OA: goldTopics (52)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, OpenAlex)SDGs (4)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 18%Citation Network 82%

Base Score Contribution

0.866

From this paper's citation signal

Citation Network Contribution

3.9

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

Impact of fecal microbiota transplantation with capsules on the prevention of metabolic syndrome among patients with obesity
HORMONES202142 citations6 referencesContributes 0.627
Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial
Gut2021243 citations33 referencesContributes 0.167
Effects of Fecal Microbiome Transfer in Adolescents With Obesity
JAMA Network Open2020173 citations34 referencesContributes 0.152
Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery
JAMA Network Open202257 citations34 referencesContributes 0.119
Prospective Study Reveals Host Microbial Determinants of Clinical Response to Fecal Microbiota Transplant Therapy in Type 2 Diabetes Patients
Frontiers in Cellular and Infection Microbiology202268 citations44 referencesContributes 0.096

Authors (10)

Liu Gao ORCID,Petr Stastka,Michael C. Cheney ORCID,Jasmin Mahabamunuge ORCID,Mariam Torres Soto ORCID

Live enrichment

PubMed:32150549 OpenAlex:https://openalex.org/W3009462663

Harvard Nutrition Obesity Research Center

Grant: P30 DK040561

National Institutes of Health

Grant: 1UL1TR001102

National Institutes of Health

Grant: 1UL1TR002541-0

National Institutes of Health

Grant: 5P30DK040561-23

Nutrition Obesity Research Center at Harvard

National Institutes of Health

Grant: 3P30DK040561-14S2

Harvard Clinical Nutrition Research Center

National Institutes of Health

Grant: 4UL1TR001102-04

Harvard Clinical and Translational Science Center

National Institutes of Health

Grant: 5UL1TR002541-04

The Harvard Clinical and Translational Science Center

FWCI

14.08

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003051&type=printable

publisherhttps://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1003051&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pmed.1003051

journalhttps://doi.org/10.1371/journal.pmed.1003051

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32150549

Fields of Study

Gut microbiota and healthClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disorders0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

Gastrointestinal MicrobiomeFecal Microbiota TransplantationAdultBostonDouble-Blind MethodEnergy MetabolismFemaleHumansInsulin ResistanceIntestinesMaleMiddle AgedObesityPilot ProjectsTime FactorsBiomarkersTreatment Outcome

Keywords

PlaceboMedicineInsulin resistanceGastroenterologyInternal medicinePopulationTransplantationRandomized controlled trialGut floraObesityImmunologyPathologyAdultMaleTime FactorsPilot ProjectsDouble-Blind MethodHumansRFecal Microbiota TransplantationMiddle AgedGastrointestinal MicrobiomeIntestinesTreatment OutcomeFemaleEnergy MetabolismBiomarkersResearch ArticleBoston

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

Additional file 2 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594445.v1figshare

Additional file 2 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594445figshare

Additional file 3 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594448.v1figshare

Additional file 3 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594448figshare

Additional file 4 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594451.v1figshare

Additional file 4 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594451figshare

Additional file 5 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594454.v1figshare

Additional file 5 of Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity

10.6084/m9.figshare.14594454figshare

Additional file 1 of Gut microbiota in patients with obesity and metabolic disorders — a systematic review

10.6084/m9.figshare.19092418.v1figshare

Additional file 1 of Gut microbiota in patients with obesity and metabolic disorders — a systematic review

10.6084/m9.figshare.19092418figshare

Additional file 1 of BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21

10.6084/m9.figshare.26827386.v1figshare

Additional file 1 of BCAA mediated microbiota-liver-heart crosstalk regulates diabetic cardiomyopathy via FGF21

10.6084/m9.figshare.26827386figshare

Related Papers (10)

An obesity-associated gut microbiome with increased capacity for energy harvest

N/A

1.4DataRank · unranked

Nature(2006)

co-cited

10.1038/nature05414

Health Effects of Overweight and Obesity in 195 Countries over 25 Years

N/A

1.3DataRank · unranked

New England Journal of Medicine(2017)

co-cited

10.1056/nejmoa1614362

Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

N/A

4.0DataRank · unranked

Journal of Clinical Investigation(2020)

co-cited

10.1172/jci131126

Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level

N/A

7.0DataRank · unranked

Cell Host & Microbe(2020)

co-cited

10.1016/j.chom.2020.05.013

A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood—Meat Eating Alternative Trial (SWAP-MEAT)

N/A

5.7DataRank · unranked

American Journal of Clinical Nutrition(2020)

co-cited

10.1093/ajcn/nqaa203

The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans

N/A

4.5DataRank · unranked

Journal of Clinical Investigation(2020)

co-cited

10.1172/jci134892

Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain

N/A

3.7DataRank · unranked

Gastroenterology(2020)

co-cited

10.1053/j.gastro.2020.08.041

Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth

N/A

2.8DataRank · unranked

The Journal of Clinical Endocrinology & Metabolism(2020)

co-cited

10.1210/clinem/dgaa382

Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKD

N/A

0.817DataRank · unranked

Kidney360(2020)

co-cited

10.34067/kid.0003942020

Gut-microbiota-targeted diets modulate human immune status

N/A

4.5DataRank · unranked

Cell(2021)

co-cited

10.1016/j.cell.2021.06.019